Reducing the Impact of Hypertension in Low and Middle Income Countries (U01)

The summary for the Reducing the Impact of Hypertension in Low and Middle Income Countries (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Reducing the Impact of Hypertension in Low and Middle Income Countries (U01)
	CFDA Number:	93.837
	CFDA Description:	Cardiovascular Diseases Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-HL-12-027
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Jun 02, 2011
	Creation Date:	Jun 02, 2011
	Original Closing Date for Applications:	Aug 10, 2011
	Current Closing Date for Applications:	Aug 10, 2011
	Archive Date:	Sep 10, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	230,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are allowed.
Grant Description: The National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Neurological Disorders and Stroke (NINDS) invite research grant applications focusing on effective interventions that will provide sound scientific evidence for expanding sustainable blood pressure prevention and control programs in low and middle income countries (LMICs) at the local, regional, and national level.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-hl-12-027.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Data Coordinating Center for the Cardiovascular Cell Therapy Research Network (CCTRN) (UM1); • Regional Clinical Centers for the Cardiovascular Cell Therapy Research Network (CCTRN) (UM1); • Pilot Studies to Develop and Test Novel, Low- Cost Methods for the Conduct of Clinical Trials (R01); • Pulmonary Vascular-Right Ventricular Axis Research Program (R01); • Basic Research in Calcific Aortic Valve Disease (R01); • The Relationship Between Hypertension and Inflammation; • Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and Alaska Nati...; • Weight Loss in Obese Adults with Cardiovascular Risk Factors: Clinical Interventions (U01); • CLINICAL RESEARCH IN PERIPHERAL ARTERIAL DISEASE; • SPECIALIZED CENTERS OF CLINICALLY ORIENTED RESEARCH (SCCOR) IN CARDIAC DYSFUNCTION AND DISEASE